source
- Novartis climbs on upbeat drug sales as key readouts loomA return to quarterly sales growth boosted shares higher on Tuesday, though a handful of coming study results will have a bigger impact on the company’s long-term outlook.BioPharma Dive · 9d ago↗ source
- STAT+: Advocates say federal funding is being cut from groups fighting HIVThe administration is shifting some funding to states, but community groups are set to lose out.STAT · 9d ago↗ source
- Is there an exodus underway at Epic?In this edition of STAT Health Tech: executive departures at Epic Systems, new CEO takes over at Nabla, and more health tech news.STAT · 9d ago↗ source